Search Results
Oct 21, 2025, 10:00 ET Green Bay Insurance Center Joins World Insurance Associates
personal insurance and bonds, employee and executive benefits, wealth management and retirement plan services, private client services, and payroll & HR solutions. For more information, please visit
More news about: WORLD INSURANCE ASSOCIATES LLC
Oct 21, 2025, 09:27 ET Dallas ISD Further Invests in Modernizing Its Data with Abre
finance into one secure AI-enabled platform supporting strategic planning, leadership teams, and staff in the areas of academics, operations, finance, HR, student services, and community engagement. Districts using Abre have reduced chronic absenteeism by 35%+, streamlined MTSS workflows to save hundreds
More news about: Abre
Oct 21, 2025, 09:06 ET Findem Raises $51 Million to Transform How Companies Hire with the World's Largest Expert-Labeled Talent Dataset
of America's most innovative companies. From Automation to Strategic ImpactAI is reshaping HR, and the breakthrough lies in domain-specific AI that can elevate recruiting beyond task automation to measurable business impact. Most recruiting technologies
More news about: Findem
Oct 21, 2025, 09:00 ET Lattice Debuts Habits and AI Agent Plus: Where People + AI is the New Way to Work
all-in-one people platform, giving HR teams everything they need for HR, Talent, and AI — together in one place. The platform seamlessly integrates a modern HRIS with performance management, engagement insights, AI-driven analytics, payroll, and career development tools, giving HR teams everything they need
More news about: Lattice
Oct 21, 2025, 09:00 ET Passwork Introduces Customizable Vault Types for Superior SysAdmin Access Control
Unlimited Custom Vault Types: Organize vaults by department (e.g., IT, Finance, HR) or project, with predefined access rules and permissions. Automatic Administrator Assignment:
More news about: Passwork
Oct 21, 2025, 08:49 ET MidCap Advisors Guides Innovative Insurance Group in Landmark Sale to ALKEME Insurance
Innovative Insurance Group has built a reputation for its deep carrier relationships, consultative expertise, and leadership in employee benefits, HR, and ACA compliance. The firm's strong East Coast presence and experienced leadership team position it as a cornerstone of ALKEME's expanding benefits
More news about: MidCap Advisors
Oct 21, 2025, 08:36 ET The Vitamin Shoppe® Appoints Retail Veteran Kate Vukelich as Executive Vice President and Chief People Officer
Staff and HR Integration Executive at Massmart, Walmart's South African subsidiary, where she helped align Walmart's global values with local operations during a period of significant expansion. "Kate is an exceptional leader who brings a rare combination of deep HR expertise and
More news about: The Vitamin Shoppe
Oct 21, 2025, 08:05 ET Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
Defense's (JPEO-CBRND) Joint Project Lead for CBRND Enabling Biotechnologies (JPL CBRND EB) in collaboration with the Defense Health Agency (DHA). (Award HR0011-21-9-0001 to D.B.W.) Penn and Dr. Weiner have either received, or may receive in the future, financial consideration related
More news about: INOVIO Pharmaceuticals, Inc.
Oct 21, 2025, 08:00 ET Josh Bersin Company Defines the New Role of Management in the Age of AI
The Josh Bersin Company, the world's most trusted HR advisory firm, today announces the release of a special new report,
More news about: The Josh Bersin Company
Oct 21, 2025, 08:00 ET Atossa Therapeutics Highlights Progress in RECAST™ DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine Agents
Phase: 2 (platform) Population: HR-positive DCIS (any grade) Arms: Tamoxifen/AI (control), (Z)-Endoxifen, elacestrant, Hav-088
More news about: Atossa Therapeutics Inc
Oct 20, 2025, 12:00 ET NOVATAE RISK GROUP NAMES KIMBERLY JENKINS AS NEW COO
personal insurance and bonds, employee and executive benefits, wealth management and retirement plan services, private client services and payroll & HR solutions. For more information, please visit
More news about: Novatae Risk Group
Oct 20, 2025, 11:10 ET The Future of the CIO: Jordi Damià, CEO of Grupo Setesca, to Speak at Info-Tech LIVE 2025 in Barcelona
Info-Tech Research Group is the world's leading research and advisory firm, proudly serving over 30,000 IT, HR, and marketing professionals. The company produces unbiased, highly relevant research and provides industry-leading advisory services to help leaders
More news about: Info-Tech Research Group
Oct 20, 2025, 10:15 ET Sinecure, Inc. Acquires The Second Shift, Expanding its Total Talent Solution Framework to Power a New Era in On-Demand Work
Founded in 2014, The Second Shift has become a trusted resource for companies seeking senior-level expertise in marketing, finance, HR and other key functions. Its network has built a reputation for both the caliber of its talent pool and the speed and efficiency of its matching process.
More news about: Sinecure, Inc.
Oct 20, 2025, 10:01 ET Patient Safety and Risk Software Market worth $2.99 billion by 2030 with 11.3% CAGR | MarketsandMarkets™
underwriting, employee health and safety, governance, risk and compliance (GRC), and exposure tracking. It integrates seamlessly with external systems such as HR, ERP, and EHS platforms, enabling organizations to unify processes across the value chain. RLDatix (US)
More news about: MarketsandMarkets
Oct 20, 2025, 09:00 ET 365Talents Launches "Job Architect," the AI HR Agent Turning Job Intelligence into Action
HRTech leader 365Talents today announced the launch of Job Architect, a free AI-powered HR agent that helps organizations instantly create, refine, and visualize their job frameworks and skill maps. Designed to combine HR expertise with AI speed and clarity, Job Architect enables teams to move from a blank
More news about: 365Talents
Oct 20, 2025, 09:00 ET AuditBoard and Protiviti Launch New AI Integrations to Elevate GRC Teams, Transform Risk Insights into Strategic Business Value
independent and locally owned member firms provide clients with consulting and managed solutions in finance, technology, operations, data, digital, legal, HR, risk and internal audit through a network of more than 90 offices in over 25 countries. Named to the Fortune 100 Best Companies
More news about: AuditBoard, Inc
Oct 20, 2025, 08:39 ET meQuilibrium Honors IBM, GE Aerospace, Ford, Citizens, ABB, and Roman Grubbs, PhD, Charles River Labs, for Achievements in Supporting Employee Resilience
proactive workforce mental health and performance solutions, has announced the winners of its annual 2025 Resilience Awards, which honor exceptional HR leaders and organizations for their achievements in workforce well-being. The 2025 Resilience Champion of the Year was awarded to Roman Grubbs, Ph.D.,
More news about: meQuilibrium
Oct 20, 2025, 08:15 ET Covenant HR Introduces Covenant AI: Elite AI Talent. Exceptional Outcomes.
increasingly AI-driven world. Covenant HR Expands Board with AI Industry Leader, Jason G. Cooper In alignment with this launch, Covenant HR is also proud to announce the addition of Jason G. Cooper, MS, FACHDM, to its
More news about: Covenant HR
Oct 20, 2025, 08:00 ET Workleap's AI-Powered Performance Solution Transforms Goals, Reviews, Feedback into Seamless Cycle
has been building game-changing products that tackle HR and ITʼs biggest challenges. Workleap operates two distinct product lines: The Workleap Platform, an AI-powered HR solution designed to drive team performance and boost
More news about: Workleap
Oct 20, 2025, 07:00 ET Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025
months in the Sirexatamab Arm compared to 7.06 months in the Control Arm, Hazard Ratio (HR) 0.61, p-value = 0.0255.mOS was not reached in the Sirexatamab Arm compared to 14.39 months in the Control Arm, HR 0.42, p-value = 0.0118. Across the DKK1-high (upper
More news about: Leap Therapeutics, Inc.
Oct 20, 2025, 06:09 ET IBM and Groq Partner to Accelerate Enterprise AI Deployment with Speed and Scale
technology is also being applied in non-regulated industries. IBM clients across retail and consumer packaged goods are using Groq for HR agents to help enhance automation of HR processes and increase employee productivity. "Many large enterprise organizations have a range of options
More news about: IBM
Oct 20, 2025, 06:00 ET Cedar Launches Cedar Cover to Help Hospitals Navigate the Medicaid and Affordability Crisis
deductibles and coinsurance have left millions of Americans with medical debt, while policy changes introduced under the One Big Beautiful Bill Act (HR1) are pushing millions more into the ranks of the uninsured. These are not edge cases — they are teachers, service workers, and small business owners
More news about: Cedar
Oct 20, 2025, 04:57 ET The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC
sac-TMT group and 4.3 months in the chemotherapy group (hazard ratio (HR), 0.49; 95% confidence interval (CI), 0.39 to 0.62; two-sided P<0.0001). OS was significantly longer with sac-TMT than with chemotherapy (HR, 0.60; 95% CI, 0.44 to 0.82; two-sided P=0.001); 18-month OS rate
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 20, 2025, 02:44 ET ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma
13.1 months, more than doubling the 6.5 months in the chemotherapy group and reducing the risk of disease progression or death by 64% (Hazard Ratio [HR] =0.36, 95% CI: 0.28 - 0.46, P < 0.0001). The OS data were equally exciting. In this interim survival analysis, the median
More news about: RemeGen Co., Ltd
Oct 20, 2025, 01:44 ET Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
botidotin than in T-DM1 (11.1 months vs 4.4 months; HR: 0.39, 95% CI, 0.30-0.51, p<0.0001). PFS benefit with trastuzumab botidotin was consistently observed regardless of prior lines of anti-HER2 therapy (HR 0.36, 95% CI, 0.25-0.53, for 1 prior line; HR 0.39, 95% CI, 0.28-0.56, for ≥2 prior lines).
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.